About Capstan Therapeutics
Capstan Therapeutics is a company based in San Diego (United States) founded in 2021 by Christian Homsy and Haig Aghajanian was acquired by AbbVie in July 2025. Capstan Therapeutics has raised $340 million across 3 funding rounds from investors including AbbVie, Lilly and Pfizer. Capstan Therapeutics offers products and services including Science Platform. Capstan Therapeutics operates in a competitive market with competitors including Moderna, BeiGene, Incyte, MorphoSys and Sana Biotechnology, among others.
- Headquarter San Diego, United States
- Founders Christian Homsy, Haig Aghajanian
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Capstan Therapeutics
Capstan Therapeutics offers a comprehensive portfolio of products and services, including Science Platform.
Platform for advancing therapeutics pipelines
People of Capstan Therapeutics
Unlock access to complete
Unlock access to complete
Funding Insights of Capstan Therapeutics
Capstan Therapeutics has successfully raised a total of $340M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $175 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Capstan Therapeutics
Capstan Therapeutics has secured backing from 16 investors, including institutional and venture fund investors. Prominent investors backing the company include AbbVie, Lilly and Pfizer.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on lifescience and healthcare sectors
|
Locked | Locked | Locked | |
|
Venture capital firm backed by Johnson & Johnson
|
Locked | Locked | Locked | |
|
Health-tech companies are targeted for venture capital investments.
|
Locked | Locked | Locked |
Investor details for Capstan Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Capstan Therapeutics
Investment portfolio details for Capstan Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Capstan Therapeutics
Detailed financials for Capstan Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Capstan Therapeutics Comparisons
Peer comparison for Capstan Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Capstan Therapeutics
Capstan Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BeiGene, Incyte, MorphoSys and Sana Biotechnology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Small molecules are developed for cancer and skin disease treatments.
|
|
| Locked | Locked | Locked |
Therapeutic antibodies for cancer and other diseases are developed.
|
|
| Locked | Locked | Locked |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| Locked | Locked | Locked |
Developer of antibodies to treat complement-mediated neurodegenerative diseases
|
Detailed competitors of Capstan Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Capstan Therapeutics
Complete news archive for Capstan Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Capstan Therapeutics
Capstan Therapeutics was founded in 2021.
Capstan Therapeutics is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Laura Shawver is the current CEO of Capstan Therapeutics.
Capstan Therapeutics is a funded company, having raised a total of $340M across 3 funding rounds to date.
Capstan Therapeutics was founded in 2021 and is based in San Diego, United States. Focus is placed on biotechnology, specifically the development of cell therapies targeting oncology, fibrosis, inflammation-related conditions, and monogenic blood disorders. Targeted lipid nanoparticles, CAR-based immunotherapy, and nucleic acid delivery systems are employed to create treatment options. Operations center on advancing these technologies for patient applications in the sector.
Capstan Therapeutics's top competitors include Moderna, BeiGene and Janux Therapeutics.
Capstan Therapeutics offers Science Platform.